Hennion & Walsh Asset Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24M Buy
568,845
+233,633
+70% +$2.2M 0.18% 136
2026
Q1
$2.73M Buy
335,212
+40,407
+14% +$347K 0.09% 281
2025
Q4
$3.06M Buy
294,805
+79,955
+37% +$839K 0.11% 247
2025
Q3
$1.9M Buy
214,850
+28,920
+16% +$206K 0.07% 360
2025
Q2
$1.07M Buy
185,930
+66,114
+55% +$405K 0.04% 479
2025
Q1
$791K Sell
119,816
-3,099
-3% -$24.1K 0.04% 528
2024
Q4
$1.07M Sell
122,915
-1,254
-1% -$18K 0.05% 448
2024
Q3
$2.43M Sell
124,169
-3,450
-3% -$69.9K 0.11% 232
2024
Q2
$2.63M Sell
127,619
-54,055
-30% -$1.11M 0.14% 200
2024
Q1
$3.88M Buy
181,674
+54,031
+42% +$1.05M 0.21% 123
2023
Q4
$1.84M Buy
127,643
+76,943
+152% +$757K 0.1% 258
2023
Q3
$462K Buy
50,700
+2,013
+4% +$20.4K 0.03% 539
2023
Q2
$515K Sell
48,687
-1,312
-3% -$15.5K 0.03% 501
2023
Q1
$611K Sell
49,999
-1,581
-3% -$19.7K 0.04% 463
2022
Q4
$640K Buy
51,580
+6,430
+14% +$93.5K 0.04% 443
2022
Q3
$617K Buy
45,150
+11,242
+33% +$173K 0.04% 435
2022
Q2
$622K Buy
+33,908
New +$488K 0.04% 442

Other funds holding KURA